A Prospective Economic Analysis of Early Outcome Data from the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial of Bendamustine-Rituximab Compared with Ibrutinib-Based Regimens in Untreated Older Patients with Chronic Lymphocytic Leukemia
Clinical Lymphoma Myeloma & Leukemia（2021）
关键词
Economic analysis,Chronic lymphocytic leukemia,Ibrutinib,Bendamustine-rituximab,Phase III trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要